This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study sample
Power calculations relating to the sample size were performed. A minimum of 3,600 patients in phase I and 1,200 in phase II was required to detect a relative difference in survival of 50% from phase I to phase II based on alpha of 0.05, beta of 0.20, baseline survival of 4.0%, and a 3:1 ratio of phase I to phase II to minimise duration of phase II. 4,690 consecutive patients were enrolled in Phase I of the study with a mean (SD) age of 68.1 (13.9) and 1,641 consecutive patients in Phase II with a mean (SD) age of 69 (13.7). Excluded patients were those younger than 16 years, those who had trauma, or whose arrests were clearly of non-cardiac aetiology.
Study design
The study was a non-randomized trial with historical controls comparing survival 36 months before (phase I) and 12 months after (phase II) system optimisation. The study was carried out in 19 urban and suburban communities (populations ranging from 16,000 to 750,000). One additional eligible community was excluded from the study because it did not meet the rapid response criteria. Loss to follow-up was not reported. The study interventions were overseen through a central advisory committee. Patient and dispatch data relied on centralised and standardised record keeping systems.
Analysis of effectiveness
The principle (intention to treat or treatment completers only) used in the analysis of effectiveness was not explicitly specified. The main health outcome measure used in the analysis was the survival rate to hospital discharge and, as a result, the number of additional lives saved each year. Only phase II patients were followed-up at 1 year to determine survival, neurological function according to a 5-point scale of Cerebral Performance Category and quality of life by means of Health Utility Index. Other survival measures were collected according to Utstein style, such as return of spontaneous circulation and admission to a hospital. Patients in both phases had similar clinical and demographic characteristics. Logistic regression analysis was performed to control for potential confounding variables.
Effectiveness results
The proportion of cases meeting the 8-minute response criterion increased from 76.7% to 92.5% (p<.001). Overall survival to hospital discharge improved from 3.9% to 5.2% (p = 0.03). The 33% increase in survival represents 21 additional lives saved each year in the study communities (approx. 1 life per 120,000 residents). Based on functional and global health criteria, the quality of life of the survivors was reported to be very good.
